Literature DB >> 25187551

On the laws of virus spread through cell populations.

Dominik Wodarz1, Chi N Chan2, Benjamin Trinité2, Natalia L Komarova1, David N Levy3.   

Abstract

UNLABELLED: The dynamics of viral infections have been investigated extensively, often with a combination of experimental and mathematical approaches. Mathematical descriptions of virus spread through cell populations are well established in the literature and have yielded important insights, yet the formulation of certain fundamental aspects of virus dynamics models remains uncertain and untested. Here, we investigate the process of infection and, in particular, the effect of varying the target cell population size on the number of productively infected cells generated. Using an in vitro single-round HIV-1 infection system, we find that the established modeling framework cannot accurately fit the data. If the model is fit to data with the lowest number of cells and is used to predict data generated with larger cell populations, the model significantly overestimates the number of productively infected cells generated. Interestingly, this deviation becomes stronger under experimental conditions that promote mixing of cells and viruses. The reason for the deviation is that the standard model makes certain oversimplifying assumptions about the fate of viruses that fail to find a cell in their immediate proximity. We derive from stochastic processes a different model that assumes simultaneous access of the virus to multiple target cells. In this scenario, if no cell is available to the virus at its location, it has a chance to interact with other cells, a process that can be promoted by mixing of the populations. This model can accurately fit the experimental data and suggests a new interpretation of mass action in virus dynamics models. IMPORTANCE: Understanding the principles of virus growth through cell populations is of fundamental importance to virology. It helps us make informed decisions about intervention strategies aimed at preventing virus growth, such as drug treatment or vaccination approaches, e.g., in HIV infection, yet considerable uncertainty remains in this respect. An important variable in this context is the number of susceptible cells available for virus replication. How does the number of susceptible cells influence the growth potential of the virus? Besides the importance of such information for clinical responses, a thorough understanding of this is also important for the prediction of virus levels in patients and the estimation of crucial patient parameters through the use of mathematical models. This paper investigates the relationship between target cell availability and the virus growth potential with a combination of experimental and mathematical approaches and provides significant new insights.
Copyright © 2014, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Year:  2014        PMID: 25187551      PMCID: PMC4249084          DOI: 10.1128/JVI.02096-14

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  17 in total

1.  Population doubling time, phosphatase activity, and hydrogen peroxide generation in Jurkat cells.

Authors:  N W Schoene; K S Kamara
Journal:  Free Radic Biol Med       Date:  1999-08       Impact factor: 7.376

Review 2.  Modelling viral and immune system dynamics.

Authors:  Alan S Perelson
Journal:  Nat Rev Immunol       Date:  2002-01       Impact factor: 53.106

3.  How should pathogen transmission be modelled?

Authors:  H McCallum; N Barlow; J Hone
Journal:  Trends Ecol Evol       Date:  2001-06-01       Impact factor: 17.712

Review 4.  A perspective on modelling hepatitis C virus infection.

Authors:  J Guedj; L Rong; H Dahari; A S Perelson
Journal:  J Viral Hepat       Date:  2010-08-15       Impact factor: 3.728

5.  Structural and practical identifiability analysis of partially observed dynamical models by exploiting the profile likelihood.

Authors:  A Raue; C Kreutz; T Maiwald; J Bachmann; M Schilling; U Klingmüller; J Timmer
Journal:  Bioinformatics       Date:  2009-06-08       Impact factor: 6.937

6.  Relative contribution of free-virus and synaptic transmission to the spread of HIV-1 through target cell populations.

Authors:  Natalia L Komarova; Daniela Anghelina; Igor Voznesensky; Benjamin Trinité; David N Levy; Dominik Wodarz
Journal:  Biol Lett       Date:  2012-12-26       Impact factor: 3.703

7.  ODE models for oncolytic virus dynamics.

Authors:  Natalia L Komarova; Dominik Wodarz
Journal:  J Theor Biol       Date:  2010-01-18       Impact factor: 2.691

8.  Mathematical modeling of tumor therapy with oncolytic viruses: regimes with complete tumor elimination within the framework of deterministic models.

Authors:  Artem S Novozhilov; Faina S Berezovskaya; Eugene V Koonin; Georgy P Karev
Journal:  Biol Direct       Date:  2006-02-17       Impact factor: 4.540

9.  Modeling of cancer virotherapy with recombinant measles viruses.

Authors:  Zeljko Bajzer; Thomas Carr; Kresimir Josić; Stephen J Russell; David Dingli
Journal:  J Theor Biol       Date:  2008-02-01       Impact factor: 2.691

Review 10.  Modeling the within-host dynamics of HIV infection.

Authors:  Alan S Perelson; Ruy M Ribeiro
Journal:  BMC Biol       Date:  2013-09-03       Impact factor: 7.431

View more
  5 in total

1.  Tat controls transcriptional persistence of unintegrated HIV genome in primary human macrophages.

Authors:  Beatrix Meltzer; Deemah Dabbagh; Jia Guo; Fatah Kashanchi; Mudit Tyagi; Yuntao Wu
Journal:  Virology       Date:  2018-03-15       Impact factor: 3.616

Review 2.  Computational modeling approaches to the dynamics of oncolytic viruses.

Authors:  Dominik Wodarz
Journal:  Wiley Interdiscip Rev Syst Biol Med       Date:  2016-03-22

Review 3.  Fighting Cancer with Mathematics and Viruses.

Authors:  Daniel N Santiago; Johannes P W Heidbuechel; Wendy M Kandell; Rachel Walker; Julie Djeu; Christine E Engeland; Daniel Abate-Daga; Heiko Enderling
Journal:  Viruses       Date:  2017-08-23       Impact factor: 5.048

4.  Oncolytic potency and reduced virus tumor-specificity in oncolytic virotherapy. A mathematical modelling approach.

Authors:  Khaphetsi Joseph Mahasa; Amina Eladdadi; Lisette de Pillis; Rachid Ouifki
Journal:  PLoS One       Date:  2017-09-21       Impact factor: 3.240

5.  In vitro and in silico multidimensional modeling of oncolytic tumor virotherapy dynamics.

Authors:  David R Berg; Chetan P Offord; Iris Kemler; Matthew K Ennis; Lawrence Chang; George Paulik; Zeljko Bajzer; Claudia Neuhauser; David Dingli
Journal:  PLoS Comput Biol       Date:  2019-03-05       Impact factor: 4.475

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.